Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors

NCT06569108 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A Without Inhibitor
Hemophilia B Without Inhibitor

Interventions

DRUG: KN057

Sponsor

Suzhou Alphamab Co., Ltd.